Hexaplex 450 mg Axio Labs

Description

Hexaplex 450 mg Axio Labs — multi-ester trenbolone blend from Axio Labs at 450 mg. Acetate provides 24-hour onset, enanthate or hexahydrobenzylcarbonate maintain levels for 7–14 days. Comprehensive trenbolone activity in a single injection.

Key Benefits

• Multi-ester 19-nor trenbolone — acute kick + sustained coverage
• Typical mix: acetate + enanthate + hexahydrobenzylcarbonate
• Injection frequency every 3–4 days sufficient
• Active molecule identical to single-ester tren at AR level
• Same side-effect burden as standalone tren — blend isn’t softer
• Each unit dosed at 450 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 150–300 mg/week split across 2–3 injections. The acetate fraction peaks within a day while longer esters build steady-state over 3–4 weeks. Cycles 10–12 weeks.

How It Works

Blend of trenbolone acetate, enanthate, and hexahydrobenzylcarbonate (parabolan) — all three are 19-nor derivatives with the same extreme AR affinity as single-ester trenbolone. Progestagenic. The blend provides staggered release: acetate in ~24 h, enanthate ~7 days, hexa ~10 days. At the receptor level the active molecule is identical across esters.

Pharmacokinetics

Composite release profile. Faster kick-in than pure enanthate, flatter serum than pure acetate. Injection frequency every 3–4 days adequate. Steady-state in 3–4 weeks.

Potential Side Effects

Identical to single-ester tren: prolactin rise, night sweats, insomnia, CV stress, aggression. Caber 0.25 mg 2×/week mandatory. Bloodwork including prolactin at week 6.

Cycle & Stacking Guide

Cutting and recomp cycles 10–12 weeks. Test E 300–500 mg/week + tren blend 200–300 mg/week. Attention to sleep, resting HR, and lipids throughout. Not for first or second cycles.

Manufacturer Notes

Axio Labs has maintained a long international presence with batch-specific authenticity codes. Their injectables use ethyl oleate or MCT carriers for low PIP.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.